2023-04-27 16:05:15 ET
- DexCom press release ( NASDAQ: DXCM ): Q1 Non-GAAP EPS of $0.17 beats by $0.02 .
- Revenue of $741.5M (+17.9% Y/Y) beats by $20.98M .
-
2023 Annual Guidance
The company is updating fiscal year 2023 revenue guidance, and reiterating guidance for Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin and Adjusted EBITDA Margin at the following levels:
- Revenue of approximately $3.400 - 3.515 billion (17-21% growth) vs. $3.46B consensus
- Non-GAAP Gross Profit Margin of 62-63%
- Non-GAAP Operating Margin of approximately 16.5%
- Adjusted EBITDA Margin of approximately 26%
For further details see:
DexCom Non-GAAP EPS of $0.17 beats by $0.02, revenue of $741.5M beats by $20.98M